CDC MMWR Review Pools Decade of US Data on Post-Acute COVID-19 Sequelae

A CDC analysis of national surveillance and cohort data from 2021 through 2023 shows that Long COVID, defined as symptoms persisting four weeks or longer after acute infection, affects an estimated 6 percent to 19 percent of US adults. The synthesis draws on representative surveys and large health system records to map prevalence alongside demographic and clinical patterns. These figures matter because they highlight ongoing population-level effects from SARS-CoV-2 beyond the initial illness phase.

Prevalence across US adults

The report found prevalence estimates vary by survey method, population sampled, and exact symptom duration used in the definition. One analysis placed the range at roughly 6 percent to 19 percent among adults. [1] Self-reported data from nationally representative samples formed the core of these calculations.

CDC data shows Long COVID prevalence among US adults ranges from 6% to 19%, with higher rates among older adults, women, people with certain health conditions, and unvaccinated individuals. Hospitalization during acute COVID-19 is the strongest risk factor.

Populations facing elevated risk

Older adults, women, and people with certain underlying conditions showed higher odds of reporting prolonged symptoms. Obesity, autoimmune disorders, and prior mental health diagnoses appeared consistently linked to increased likelihood. [2] Hospitalization during the acute phase marked the strongest single predictor across the datasets examined.

Demographic and socioeconomic patterns

Black, Hispanic, and other minority groups reported Long COVID symptoms at higher rates than White adults in several cohorts. These differences aligned with documented disparities in exposure risk and access to follow-up care. [3] Socioeconomic barriers also correlated with both symptom reporting and clinical recognition.

Role of vaccination status

Unvaccinated individuals carried greater risk of developing persistent symptoms compared with those who had received at least one dose. Vaccination lowered but did not remove the possibility of Long COVID entirely. [2] Data spanned periods before and after widespread booster availability.

What this means

The pooled findings describe a condition that continues to touch millions of adults nationwide, with uneven distribution across age, sex, race, and health status. They also illustrate how prior infection severity and vaccination history modify individual trajectories without eliminating the possibility of longer-term effects.

Limitations

Prevalence numbers shift with changes in question wording, diagnostic thresholds, and which groups respond to surveys. Self-reported symptoms introduce recall bias, and people too ill to participate may be underrepresented. The analyses exclude children and rely on definitions that have continued to evolve since data collection ended.

Key takeaways

• CDC surveillance places Long COVID prevalence among US adults between 6 percent and 19 percent, varying by definition and sample. [1]
• Older age, female sex, obesity, autoimmune disease, mental health conditions, and lack of vaccination each associate with higher reported rates. [2]
• Black and Hispanic adults show elevated symptom reporting tied to exposure patterns and care access differences. [3]
• Hospitalization for acute COVID-19 marks the clearest single risk indicator across cohorts.
• Vaccination status reduces but does not erase the chance of prolonged symptoms after infection.

Last updated: August 27, 2026